Citations (128)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Khatereh Khorsandi, HomaSadat Esfahani & Heidi Abrahamse. (2021) Characteristics of circRNA and its approach as diagnostic tool in melanoma. Expert Review of Molecular Diagnostics 21:10, pages 1079-1094.
Read now
Read now
Seung-Shick Shin, Dae-Hwa Noh, Byungdoo Hwang, Jo-Won Lee, Sung Lyea Park, Sung-Soo Park, Bokyung Moon, Wun-Jae Kim & Sung-Kwon Moon. (2018) Inhibitory effect of Au@Pt-NSs on proliferation, migration, and invasion of EJ bladder carcinoma cells: involvement of cell cycle regulators, signaling pathways, and transcription factor-mediated MMP-9 expression. International Journal of Nanomedicine 13, pages 3295-3310.
Read now
Read now
Tatyana S. Nekova, Susanne Kneitz, Hermann Einsele, Ralf Bargou & Gernot Stuhler. (2016) Silencing of CDK2, but not CDK1, separates mitogenic from anti-apoptotic signaling, sensitizing p53 defective cells for synthetic lethality. Cell Cycle 15:23, pages 3203-3209.
Read now
Read now
Sarah R Hosford & Todd W Miller. (2014) Clinical potential of novel therapeutic targets in breast cancer: CDK4/6, Src, JAK/STAT, PARP, HDAC, and PI3K/AKT/mTOR pathways. Pharmacogenomics and Personalized Medicine 7, pages 203-215.
Read now
Read now
Andrea Rocca, Alberto Farolfi, Sara Bravaccini, Alessio Schirone & Dino Amadori. (2014)
Palbociclib (PD 0332991): targeting the cell cycle machinery in breast cancer. Expert Opinion on Pharmacotherapy 15:3, pages 407-420.
Read now
Read now
Orathai Uadkla, Supachai Yodkeeree, Mongkol Buayairaksa, Puttinan Meepowpan, Narong Nuntasaen, Pornngarm Limtrakul & Wilart Pompimon. (2013) Antiproliferative effect of alkaloids via cell cycle arrest from Pseuduvaria rugosa. Pharmaceutical Biology 51:3, pages 400-404.
Read now
Read now
Articles from other publishers (122)
Ritabrita Goswami, Aarohi Gupta, Olga Bednova, Gaël Coulombe, Dipika Patel, Vincent M. Rotello & Jeffrey V. Leyton. (2024) Nuclear localization signal-tagged systems: relevant nuclear import principles in the context of current therapeutic design. Chemical Society Reviews.
Crossref
Crossref
Zhixin Lan, Lu Zhao, Liang Peng, Lili Wan, Di Liu, Chengyuan Tang, Guochun Chen, Yu Liu & Hong Liu. (2023) EIF2α/ATF4 pathway enhances proliferation of mesangial cell via cyclin D1 during endoplasmic reticulum stress in IgA nephropathy. Clinical Immunology 257, pages 109840.
Crossref
Crossref
Manuel Beltrán‐Visiedo, Nelia Jiménez‐Alduán, Rosana Díez, Marta Cuenca, Andrea Benedi, Alfonso Serrano‐Del Valle, Gemma Azaceta, Luis Palomera, Victor Peperzak, Alberto Anel, Javier Naval & Isabel Marzo. (2023)
Dinaciclib synergizes with
BH3
mimetics targeting
BCL
‐2 and
BCL‐X
L
in multiple myeloma cell lines partially dependent on
MCL
‐1 and in plasma cells from patients
. Molecular Oncology 17:12, pages 2507-2525.
Crossref
Crossref
Bartosz Knap, Dorota Nieoczym, Uday Kundap, Kamila Kusio-Targonska, Wirginia Kukula-Koch, Waldemar A. Turski & Kinga Gawel. (2023) Zebrafish as a robust preclinical platform for screening plant-derived drugs with anticonvulsant properties—a review. Frontiers in Molecular Neuroscience 16.
Crossref
Crossref
Tapan K. Maity, Eun Young Kim, Constance M. Cultraro, Abhilash Venugopalan, Leena Khare, Ramulu Poddutoori, Sivapriya Marappan, Samiulla D. Syed, William G. Telford, Susanta Samajdar, Murali Ramachandra & Udayan Guha. (2023) Novel CDK12/13 Inhibitors AU-15506 and AU-16770 Are Potent Anti-Cancer Agents in EGFR Mutant Lung Adenocarcinoma with and without Osimertinib Resistance. Cancers 15:8, pages 2263.
Crossref
Crossref
Mitra Zabihi, Ramin Lotfi, Amir-Mohammad Yousefi & Davood Bashash. (2022) Cyclins and cyclin-dependent kinases: from biology to tumorigenesis and therapeutic opportunities. Journal of Cancer Research and Clinical Oncology 149:4, pages 1585-1606.
Crossref
Crossref
Binghao Zhao, Bo Wu, Nan Feng, Xiang Zhang, Xin Zhang, Yiping Wei & Wenxiong Zhang. (2023) Aging microenvironment and antitumor immunity for geriatric oncology: the landscape and future implications. Journal of Hematology & Oncology 16:1.
Crossref
Crossref
Xiao Shen, Anna-Laura Kretz, Sandra Schneider, Uwe Knippschild, Doris Henne-Bruns, Marko Kornmann, Johannes Lemke & Benno Traub. (2023) Evaluation of CDK9 Inhibition by Dinaciclib in Combination with Apoptosis Modulating izTRAIL for the Treatment of Colorectal Cancer. Biomedicines 11:3, pages 928.
Crossref
Crossref
Ah-Won Kwak, Woo-Keun Kim, Seung-On Lee, Goo Yoon, Seung-Sik Cho, Ki-Taek Kim, Mee-Hyun Lee, Yung Hyun Choi, Jin-Young Lee, Jin Woo Park & Jung-Hyun Shim. (2023) Licochalcone B Induces ROS-Dependent Apoptosis in Oxaliplatin-Resistant Colorectal Cancer Cells via p38/JNK MAPK Signaling. Antioxidants 12:3, pages 656.
Crossref
Crossref
Pinar Obakan Yerlikaya, Kaan Adacan, Ayse Karatug Kacar, Ajda Coker Gurkan & Elif Damla Arisan. (2023) Epibrassinolide impaired colon tumor progression and induced autophagy in SCID mouse xenograft model via acting on cell cycle progression without affecting endoplasmic reticulum stress observed in vitro. The International Journal of Biochemistry & Cell Biology 155, pages 106360.
Crossref
Crossref
Manzoor Ahmad Mir & Burhan Ul Haq. 2023. Therapeutic potential of Cell Cycle Kinases in Breast Cancer. Therapeutic potential of Cell Cycle Kinases in Breast Cancer
195
210
.
Manzoor Ahmad Mir & Abrar Yousuf Mir. 2023. Therapeutic potential of Cell Cycle Kinases in Breast Cancer. Therapeutic potential of Cell Cycle Kinases in Breast Cancer
149
174
.
Manzoor Ahmad Mir & Asma Jan. 2023. Therapeutic potential of Cell Cycle Kinases in Breast Cancer. Therapeutic potential of Cell Cycle Kinases in Breast Cancer
53
82
.
Manzoor Ahmad Mir & Burhan Ul Haq. 2023. Therapeutic potential of Cell Cycle Kinases in Breast Cancer. Therapeutic potential of Cell Cycle Kinases in Breast Cancer
233
252
.
Manzoor Ahmad Mir & Ulfat Jan. 2023. Therapeutic potential of Cell Cycle Kinases in Breast Cancer. Therapeutic potential of Cell Cycle Kinases in Breast Cancer
211
232
.
Manaswini Gattupalli, Parry Dey, Shanmugam Poovizhi, Riya Ben Patel, Debasish Mishra & Satarupa Banerjee. 2023. Regenerative Medicine. Regenerative Medicine
331
390
.
Sonal M. Manohar & Kalpana S. Joshi. (2022) Promising Anticancer Activity of Multitarget Cyclin Dependent Kinase
Inhibitors against Human Colorectal Carcinoma Cells. Current Molecular Pharmacology 15:7, pages 1024-1033.
Crossref
Crossref
Rui Song, Juntao Huang, Chenglei Yang, Yuankuan Li, Guohua Zhan & Bangde Xiang. (2022) ESPL1 is Elevated in Hepatocellular Carcinoma and Predicts Prognosis. International Journal of General Medicine Volume 15, pages 8381-8398.
Crossref
Crossref
Sisir Nandi & Manish C. Bagchi. (2022) Exploring CDKs, Ras-ERK, and PI3K-Aktin Abnormal Signaling and Cancer. Journal of Cancer Research Updates 11, pages 63-69.
Crossref
Crossref
Ogochukwu O. Izuegbuna. (2022) Polyphenols: Chemoprevention and therapeutic potentials in hematological malignancies. Frontiers in Nutrition 9.
Crossref
Crossref
Chuting Li, Ru Su, Xiuyuan Wang, Guiping Huang, Yanjun Liu, Juhua Yang, Zhao Yin, Chunming Gu & Jia Fei. (2022) Discovery of the oncogenic MDM2, a direct binding target of berberine and a potential therapeutic, in multiple myeloma. Functional & Integrative Genomics 22:5, pages 1031-1041.
Crossref
Crossref
Sonal M Manohar. (2022) Cyclin-dependent kinases as potential targets for colorectal cancer: past, present and future. Future Medicinal Chemistry 14:14, pages 1087-1105.
Crossref
Crossref
Liqin Wang, Lina Lankhorst & René Bernards. (2022) Exploiting senescence for the treatment of cancer. Nature Reviews Cancer 22:6, pages 340-355.
Crossref
Crossref
Sophia Adamia, Shruti Bhatt, Kenneth Wen, Zuzana Chyra, Geoffrey G. Fell, Yu-Tzu Tai, Marisa S. Pioso, Ivane Abiatari, Anthony Letai, David M. Dorfman, Teru Hideshima & Kenneth C. Anderson. (2022) Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myeloma. Leukemia 36:4, pages 1088-1101.
Crossref
Crossref
Sisir Nandi, Rishita Dey, Sudatta Dey, Asmita Samadder & Anil Kumar Saxena. (2022) Naturally Sourced CDK Inhibitors and Current Trends in Structure-Based Synthetic
Anticancer Drug Design by Crystallography. Anti-Cancer Agents in Medicinal Chemistry 22:3, pages 485-498.
Crossref
Crossref
Qing Su, Baolin Xu, Zhoubin Tian & Ziling Gong. (2021) Novel 1,3,5‐triazine‐nicotinohydrazide derivatives induce cell arrest and apoptosis in osteosarcoma cancer cells and inhibit osteosarcoma in a patient‐derived orthotopic xenograft mouse model. Chemical Biology & Drug Design 99:2, pages 320-330.
Crossref
Crossref
Pavithra Shyamsunder, Shree Pooja Sridharan, Vikas Madan, Pushkar Dakle, Cao Zeya, Deepika Kanojia, Wee-Joo Chng, S. Tiong Ong & H. Phillip Koeffler. (2022) THZ531 Induces a State of BRCAness in Multiple Myeloma Cells: Synthetic Lethality with Combination Treatment of THZ 531 with DNA Repair Inhibitors. International Journal of Molecular Sciences 23:3, pages 1207.
Crossref
Crossref
In-Hye Kim, Taekil Eom, Joon-Young Park, Hyung-Joo Kim & Taek-Jeong Nam. (2021)
Dichloromethane fractions of
Calystegia soldanella
induce S‑phase arrest and apoptosis in HT‑29 human colorectal cancer cells
. Molecular Medicine Reports 25:2.
Crossref
Crossref
Ying Zhu, Kun-Bin Ke, Zhong-Kun Xia, Hong-Jian Li, Rong Su, Chao Dong, Feng-Mei Zhou, Lin Wang, Rong Chen, Shi-Guo Wu, Hui Zhao, Peng Gu, Kwong-Sak Leung, Man-Hon Wong, Gang Lu, Jian-Ying Zhang, Bing-Hua Jiang, Jian-Ge Qiu, Xi-Nan Shi & Marie Chia-mi Lin. (2021) Discovery of vanoxerine dihydrochloride as a CDK2/4/6 triple-inhibitor for the treatment of human hepatocellular carcinoma. Molecular Medicine 27:1.
Crossref
Crossref
Yuying Fan, Xiaoli Ren, Yingxue Wang, Enshuang Xu, Shuang Wang, Ruidong Ge & Yun Liu. (2021)
Metformin inhibits the proliferation of canine mammary gland tumor cells through the AMPK/AKT/mTOR signaling pathway
in vitro
. Oncology Letters 22:6.
Crossref
Crossref
Xu Li, Jin Zhao, Tingcai Yan, Jingjing Mu, Yang Lin, Jing Chen, Haotian Deng & Xianjun Meng. (2021)
Cyanidin‐3‐
O
‐glucoside and cisplatin inhibit proliferation and downregulate the PI3K/AKT/mTOR pathway in cervical cancer cells
. Journal of Food Science 86:6, pages 2700-2712.
Crossref
Crossref
Jafar Amani, Nassim Gorjizadeh, Simin Younesi, Mojtaba Najafi, Arash M. Ashrafi, Saeed Irian, Negar Gorjizadeh & Khalil Azizian. (2021) Cyclin-dependent kinase inhibitors (CDKIs) and the DNA damage response: The link between signaling pathways and cancer. DNA Repair 102, pages 103103.
Crossref
Crossref
Sevgi Uğur MUTLUAY & Leyla Didem KOZACI. (2021) Hücre İçi Sinyal Yolaklarını Hedefleyen Kemoterapötik AjanlarChemotherapeutic Agents Targeting Intracellular Signaling Pathways. Black Sea Journal of Health Science 4:2, pages 175-184.
Crossref
Crossref
Priscilla K. Brastianos, Albert E. Kim, Nancy Wang, Eudocia Q. Lee, Jennifer Ligibel, Justine V. Cohen, Ugonma N. Chukwueke, Maura Mahar, Kevin Oh, Michael D. White, Helen A. Shih, Deborah Forst, Justin F. Gainor, Rebecca S. Heist, Elizabeth R. Gerstner, Tracy T. Batchelor, Donald Lawrence, David P. Ryan, A. John Iafrate, Anita Giobbie-Hurder, Sandro Santagata, Scott L. Carter, Daniel P. Cahill & Ryan J. Sullivan. (2021) Palbociclib demonstrates intracranial activity in progressive brain metastases harboring cyclin-dependent kinase pathway alterations. Nature Cancer 2:5, pages 498-502.
Crossref
Crossref
Hai-Long Qin, Xue-Jun Wang, Bi-Xian YangBin DuXue-Lin Yun. (2021) Notoginsenoside R1 attenuates breast cancer progression by targeting CCND2 and YBX3. Chinese Medical Journal 134:5, pages 546-554.
Crossref
Crossref
Divya L. Dayanidhi, Beatrice C. Thomas, Joshua S. Osterberg, Mallissa Vuong, Giselle Vargas, Sarah K. Kwartler, Emma Schmaltz, Meagan M. Dunphy-Daly, Thomas F. Schultz, Daniel Rittschof, William C. Eward, Christopher Roy & Jason A. Somarelli. (2021) Exploring the Diversity of the Marine Environment for New Anti-cancer Compounds. Frontiers in Marine Science 7.
Crossref
Crossref
Saikat Dewanjee, Sonjit Das, Swarnalata Joardar, Simanta Bhattacharjee & Pratik Chakraborty. 2021. Carotenoids: Structure and Function in the Human Body. Carotenoids: Structure and Function in the Human Body
475
512
.
Shin Young Park, Ki Yun Kim, Do Youn Jun, Su-Kyeong Hwang & Young Ho Kim. (2020) G1 Cell Cycle Arrest and Extrinsic Apoptotic Mechanisms Underlying the Anti-Leukemic Activity of CDK7 Inhibitor BS-181. Cancers 12:12, pages 3845.
Crossref
Crossref
Liang-Tsai Yeh, Li-Sung Hsu, Yi-Hsuan Chung & Chih-Jung Chen. (2020) Tectorigenin Inhibits Glioblastoma Proliferation by G0/G1 Cell Cycle Arrest. Medicina 56:12, pages 681.
Crossref
Crossref
Daniel J. Baillache & Asier Unciti-Broceta. (2020)
Recent developments in anticancer kinase inhibitors based on the pyrazolo[3,4-
d
]pyrimidine scaffold
. RSC Medicinal Chemistry 11:10, pages 1112-1135.
Crossref
Crossref
Jing-Yu Liu, Xiao-Xiao Hou, Zhuo-Yu Li, Shu-Hua Shan, Ming-Chang Chang, Cui-Ping Feng & Yin Wei. (2020) Isolation and structural characterization of a novel polysaccharide from Hericium erinaceus fruiting bodies and its arrest of cell cycle at S-phage in colon cancer cells. International Journal of Biological Macromolecules 157, pages 288-295.
Crossref
Crossref
Stefan Siebert, Arthur G. Pratt, Deborah D. Stocken, Miranda Morton, Amy Cranston, Michael Cole, Sheelagh Frame, Christopher D. BuckleyWan-Fai Ng, Andrew Filer, Iain B. McInnes & John D. Isaacs. (2020) Targeting the rheumatoid arthritis synovial fibroblast via cyclin dependent kinase inhibition. Medicine 99:26, pages e20458.
Crossref
Crossref
Abbas Abi, Najmeh Farahani, Ghader Molavi & Seyed Mohammad Gheibi Hayat. (2019) Circular RNAs: epigenetic regulators in cancerous and noncancerous skin diseases. Cancer Gene Therapy 27:5, pages 280-293.
Crossref
Crossref
Lei Ding, Jiaqi Cao, Wen Lin, Hongjian Chen, Xianhui Xiong, Hongshun Ao, Min Yu, Jie Lin & Qinghua Cui. (2020) The Roles of Cyclin-Dependent Kinases in Cell-Cycle Progression and Therapeutic Strategies in Human Breast Cancer. International Journal of Molecular Sciences 21:6, pages 1960.
Crossref
Crossref
Przemysław Czeleń. (2019) Investigation of the Inhibition Potential of New Oxindole Derivatives and Assessment of Their Usefulness for Targeted Therapy. Symmetry 11:8, pages 974.
Crossref
Crossref
Chia-Hsiang Fu, Ta-Jen Lee, Chi-Che Huang, Po-Hung Chang, Jung-Wei Tsai, Li-Pang Chuang & Jong-Hwei Su Pang. (2019) Simvastatin inhibits the proliferation of HL-60 clone 15- derived eosinophils by inducing the arrest of the cell cycle in the G1/S phase. European Journal of Pharmacology 856, pages 172400.
Crossref
Crossref
Przemysław Czeleń & Beata Szefler. (2019) The Immobilization of Oxindole Derivatives with Use of Cube Rhombellane Homeomorphs. Symmetry 11:7, pages 900.
Crossref
Crossref
Peng Huang, Li-Ying Sun & Yan-Qiao Zhang. (2019) A Hopeful Natural Product, Pristimerin, Induces Apoptosis, Cell Cycle Arrest, and Autophagy in Esophageal Cancer Cells. Analytical Cellular Pathology 2019, pages 1-10.
Crossref
Crossref
Priscylla Andrade Volkart, Gabriela Bitencourt-Ferreira, André Arigony Souto & Walter Filgueira de Azevedo. (2019) Cyclin-Dependent Kinase 2 in Cellular Senescence and Cancer. A Structural and Functional Review. Current Drug Targets 20:7, pages 716-726.
Crossref
Crossref
Daphne Brisard, Frank Eckerdt, Lindsey A. Marsh, Gavin T. Blyth, Sarika Jain, Massimo Cristofanilli, Dai Horiuchi & Leonidas C. Platanias. (2018) Antineoplastic effects of selective CDK9 inhibition with atuveciclib on cancer stem-like cells in triple-negative breast cancer. Oncotarget 9:99, pages 37305-37318.
Crossref
Crossref
Venugopal Vinod Prabhu, Perumal Elangovan, Sivasithambaram Niranjali Devaraj & Kunnathur Murugesan Sakthivel. (2018) Targeting apoptosis by 1,2-diazole through regulation of EGFR, Bcl-2 and CDK-2 mediated signaling pathway in human non-small cell lung carcinoma A549 cells. Gene 679, pages 352-359.
Crossref
Crossref
Eva Novotná, Neslihan Büküm, Jakub Hofman, Michaela Flaxová, Etela Kouklíková, Dagmar Louvarová & Vladimír Wsól. (2018) Roscovitine and purvalanol A effectively reverse anthracycline resistance mediated by the activity of aldo-keto reductase 1C3 (AKR1C3): A promising therapeutic target for cancer treatment. Biochemical Pharmacology 156, pages 22-31.
Crossref
Crossref
Kohei Morita, Tomomi Fujii, Hiroe Itami, Tomoko Uchiyama, Tokiko Nakai, Kinta Hatakeyama, Aya Sugimoto, Makito Miyake, Yasushi Nakai, Nobumichi Tanaka, Keiji Shimada, Masaharu Yamazaki, Kiyohide Fujimoto & Chiho Ohbayashi. (2018) NACC1, as a Target of MicroRNA-331-3p, Regulates Cell Proliferation in Urothelial Carcinoma Cells. Cancers 10:10, pages 347.
Crossref
Crossref
Giancarlo Barone, Arvind Arora, Anil Ganesh, Tarek Abdel-Fatah, Paul Moseley, Reem Ali, Stephen YT Chan, Constantinos Savva, Kristina Schiavone, Natasha Carmell, Katie N. Myers, Emad A. Rakha, Srinivasan Madhusudan & Spencer J. Collis. (2018) The relationship of CDK18 expression in breast cancer to clinicopathological parameters and therapeutic response. Oncotarget 9:50, pages 29508-29524.
Crossref
Crossref
Dauren Alimbetov, Sholpan Askarova, Bauyrzhan Umbayev, Terence Davis & David Kipling. (2018) Pharmacological Targeting of Cell Cycle, Apoptotic and Cell Adhesion Signaling Pathways Implicated in Chemoresistance of Cancer Cells. International Journal of Molecular Sciences 19:6, pages 1690.
Crossref
Crossref
Andrana Karla Calgarotto, Victor Maso, Gilberto Carlos Franchi Junior, Alexandre Eduardo Nowill, Paulo Latuf Filho, José Vassallo & Sara Teresinha Olalla Saad. (2018) Antitumor activities of Quercetin and Green Tea in xenografts of human leukemia HL60 cells. Scientific Reports 8:1.
Crossref
Crossref
Carlos Roberto Koscky Paier, Sarah Sant'Anna Maranhão, Teiliane Rodrigues Carneiro, Lídia Moreira Lima, Danilo Damasceno Rocha, Renan da Silva Santos, Kaio Moraes de Farias, Manoel Odorico de Moraes-Filho & Claudia Pessoa. (2018) Natural products as new antimitotic compounds for anticancer drug development. Clinics 73, pages e813s.
Crossref
Crossref
Clement Opoku-Temeng, Neetu Dayal, Delmis E. Hernandez, N. Naganna & Herman O. Sintim. (2018)
Tetrahydro-3
H
-pyrazolo[4,3-
a
]phenanthridine-based CDK inhibitor
. Chemical Communications 54:36, pages 4521-4524.
Crossref
Crossref
Sylvie Lamy, Évelyne Muhire & Borhane Annabi. (2018) Antiproliferative efficacy of elderberries and elderflowers (Sambucus canadensis) on glioma and brain endothelial cells under normoxic and hypoxic conditions. Journal of Functional Foods 40, pages 164-179.
Crossref
Crossref
Zan-Feng Xu, Xiao-Ke Sun, Gang Chen, Chao Han, Feng Wang & Yong-Dong Zhang. (2018) Oroxyloside inhibits human glioma progression by suppressing proliferation, metastasis and inducing apoptosis related pathways. Biomedicine & Pharmacotherapy 97, pages 1564-1574.
Crossref
Crossref
Monia Lenzi, Veronica Cocchi, Marco Malaguti, Maria Cristina Barbalace, Silvia Marchionni, Silvana Hrelia & Patrizia Hrelia. (2017) 6-(Methylsulfonyl) hexyl isothiocyanate as potential chemopreventive agent: molecular and cellular profile in leukaemia cell lines. Oncotarget 8:67, pages 111697-111714.
Crossref
Crossref
Zhicheng Chen, Bo Zhang, Feng Gao & Renjie Shi. (2017) Modulation of G2/M cell cycle arrest and apoptosis by luteolin in human colon cancer cells and xenografts. Oncology Letters.
Crossref
Crossref
Przemysław Czeleń. (2017) Inhibition mechanism of CDK-2 and GSK-3β by a sulfamoylphenyl derivative of indoline—a molecular dynamics study. Journal of Molecular Modeling 23:8.
Crossref
Crossref
Mu Yang & Ulrich Bierbach. (2016) Metal‐Containing Pharmacophores in Molecularly Targeted Anticancer Therapies and Diagnostics. European Journal of Inorganic Chemistry 2017:12, pages 1561-1572.
Crossref
Crossref
Seung-Shick Shin, Se Yeon Won, Dae-Hwa Noh, Byungdoo Hwang, Wun-Jae Kim & Sung-Kwon Moon. (2017) Morin Inhibits Proliferation, Migration, and Invasion of Bladder Cancer EJ Cells via Modulation of Signaling Pathways, Cell Cycle Regulators, and Transcription Factor-Mediated MMP-9 Expression. Drug Development Research 78:2, pages 81-90.
Crossref
Crossref
Jung Im Lee, In-Hye Kim & Taek-Jeong Nam. (2017) Crude extract and solvent fractions of Calystegia soldanella induce G1 and S phase arrest of the cell cycle in HepG2 cells. International Journal of Oncology 50:2, pages 414-420.
Crossref
Crossref
Anna-Laura Kretz, Monika Schaum, Julia Richter, Ella F Kitzig, Christine C Engler, Frank Leithäuser, Doris Henne-Bruns, Uwe Knippschild & Johannes Lemke. (2017) CDK9 is a prognostic marker and therapeutic target in pancreatic cancer. Tumor Biology 39:2, pages 101042831769430.
Crossref
Crossref
E.M. Redmond, C. Lally & P.A. Cahill. 2017. Cardio-Oncology. Cardio-Oncology
35
53
.
A.A. Mortlock, D.M. Wilson, J.G. Kettle, F.W. Goldberg & K.M. Foote. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
39
75
.
Richard S. Finn, Alexey Aleshin & Dennis J. Slamon. (2016) Targeting the cyclin-dependent kinases (CDK) 4/6 in estrogen receptor-positive breast cancers. Breast Cancer Research 18:1.
Crossref
Crossref
Przemysław Czeleń. (2016) Molecular dynamics study on inhibition mechanism of CDK-2 and GSK-3β by CHEMBL272026 molecule. Structural Chemistry 27:6, pages 1807-1818.
Crossref
Crossref
Giancarlo Barone, Christopher J. Staples, Anil Ganesh, Karl W. Patterson, Dominic P. Bryne, Katie N. Myers, Abhijit A. Patil, Claire E. Eyers, Sarah Maslen, J. Mark Skehel, Patrick A. Eyers & Spencer J. Collis. (2016) Human CDK18 promotes replication stress signaling and genome stability. Nucleic Acids Research 44:18, pages 8772-8785.
Crossref
Crossref
Sook-Kyoung Heo, Eui-Kyu Noh, Gi-Dong Gwon, Jeong Yi Kim, Jae-Cheol Jo, Yunsuk Choi, SuJin Koh, Jin Ho Baek, Young Joo Min & Hawk Kim. (2016) Radotinib inhibits acute myeloid leukemia cell proliferation via induction of mitochondrial-dependent apoptosis and CDK inhibitors. European Journal of Pharmacology 789, pages 280-290.
Crossref
Crossref
Rui-Ting Liu, Guo-Rong Wang, Chang Liu, Jian Qiu, Li-Kun Yan, Xiao-Jun Li & Xiao-Qiang Wang. (2016) RNAi-mediated downregulation of DNA binding protein A inhibits tumorigenesis in colorectal cancer. International Journal of Molecular Medicine 38:3, pages 703-712.
Crossref
Crossref
Meran Keshawa Ediriweera, Kamani Hemamala Tennekoon, Achyut Adhikari, Sameera Ranganath Samarakoon, Ira Thabrew & E. Dilip de Silva. (2016) New halogenated constituents from Mangifera zeylanica Hook.f. and their potential anti-cancer effects in breast and ovarian cancer cells. Journal of Ethnopharmacology 189, pages 165-174.
Crossref
Crossref
Yubing Zhou, Jacson K. Shen, Francis J. Hornicek, Quancheng Kan & Zhenfeng Duan. (2016) The emerging roles and therapeutic potential of cyclin-dependent kinase 11 (CDK11) in human cancer. Oncotarget 7:26, pages 40846-40859.
Crossref
Crossref
Adam J. DiPippo, Neelam K. Patel & Chad M. Barnett. (2016) Cyclin-Dependent Kinase Inhibitors for the Treatment of Breast Cancer: Past, Present, and Future. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 36:6, pages 652-667.
Crossref
Crossref
Cheol Park, Ji-Suk Jeong, Jin-Woo Jeong, Sung Ok Kim, Yong-Joo Kim, Gi-Young Kim, Su-Hyun Hong & Yung Hyun Choi. (2016) Ethanol extract of Kalopanax septemlobus leaf inhibits HepG2 human hepatocellular carcinoma cell proliferation via inducing cell cycle arrest at G 1 phase. Asian Pacific Journal of Tropical Medicine 9:4, pages 344-350.
Crossref
Crossref
David A. Alagpulinsa, Srinivas Ayyadevara, Shmuel Yaccoby & Robert J. Shmookler Reis. (2016) A Cyclin-Dependent Kinase Inhibitor, Dinaciclib, Impairs Homologous Recombination and Sensitizes Multiple Myeloma Cells to PARP Inhibition. Molecular Cancer Therapeutics 15:2, pages 241-250.
Crossref
Crossref
KATJA STORCH & NILS CORDES. (2016) The impact of CDK9 on radiosensitivity, DNA damage repair and cell cycling of HNSCC cancer cells. International Journal of Oncology 48:1, pages 191-198.
Crossref
Crossref
Xiaotian Kong, Huiyong Sun, Peichen Pan, Sheng Tian, Dan Li, Youyong Li & Tingjun Hou. (2016) Molecular principle of the cyclin-dependent kinase selectivity of 4-(thiazol-5-yl)-2-(phenylamino) pyrimidine-5-carbonitrile derivatives revealed by molecular modeling studies. Physical Chemistry Chemical Physics 18:3, pages 2034-2046.
Crossref
Crossref
Loredana Santo, Ka Tat Siu & Noopur Raje. (2015) Targeting Cyclin-Dependent Kinases and Cell Cycle Progression in Human Cancers. Seminars in Oncology 42:6, pages 788-800.
Crossref
Crossref
HUIXIA LU, FENG GAO, GUOFANG SHU, GUOHUA XIA, ZEYE SHAO, HANGQIN LU & KEPING CHENG. (2015) Wogonin inhibits the proliferation of myelodysplastic syndrome cells through the induction of cell cycle arrest and apoptosis. Molecular Medicine Reports 12:5, pages 7285-7292.
Crossref
Crossref
Sandra-Annika Quast, Katja Steinhorst, Michael Plötz & Jürgen Eberle. (2015) Sensitization of Melanoma Cells for Death Ligand TRAIL Is Based on Cell Cycle Arrest, ROS Production, and Activation of Proapoptotic Bcl-2 Proteins. Journal of Investigative Dermatology 135:11, pages 2794-2804.
Crossref
Crossref
Lata Singh, Neelam Pushker, Seema Sen, Mithalesh K Singh, Feeroj A Chauhan & Seema Kashyap. (2015) Prognostic significance of polo‐like kinases in retinoblastoma: correlation with patient outcome, clinical and histopathological parameters. Clinical & Experimental Ophthalmology 43:6, pages 550-557.
Crossref
Crossref
El?bieta Radzikowska. (2015) Lymphangioleiomyomatosis: New Treatment Perspectives. Lung 193:4, pages 467-475.
Crossref
Crossref
Daniela Cihalova, Frantisek Staud & Martina Ceckova. (2015) Interactions of cyclin-dependent kinase inhibitors AT-7519, flavopiridol and SNS-032 with ABCB1, ABCG2 and ABCC1 transporters and their potential to overcome multidrug resistance in vitro. Cancer Chemotherapy and Pharmacology 76:1, pages 105-116.
Crossref
Crossref
Seongmin Choi, Hyeong Ryul Kim, Chang Ohk Sung, Jongkyu Kim, Sukjun Kim, Sung-Min Ahn, Chang-min Choi, Sung-Min Chun, Eun Kyung Choi, Sang-We Kim, Yong-Hee Kim, Ji-Young Lee, Joon Seon Song, Deokhoon Kim, Farhan Haq, Sun Young Lee, Jong-eun Lee, Wang-rim Jung, Hye Yoon Jang, Eunho Yang, Charles Lee, Eunsil Yu, Gu Kong, Daehyun Baek & Se Jin Jang. (2015) Genomic Alterations in the RB Pathway Indicate Prognostic Outcomes of Early-Stage Lung Adenocarcinoma. Clinical Cancer Research 21:11, pages 2613-2623.
Crossref
Crossref
Yubing Zhou, Chao Han, Duolu Li, Zujiang Yu, Fengmei Li, Feng Li, Qi An, Huili Bai, Xiaojian Zhang, Zhenfeng Duan & Quancheng Kan. (2015) Cyclin-dependent kinase 11p110 (CDK11p110) is crucial for human breast cancer cell proliferation and growth. Scientific Reports 5:1.
Crossref
Crossref
Hye Young Park, Il-Whan Choi, Gi-Young Kim, Byung Woo Kim, Wun-Jae Kim & Yung Hyun Choi. (2015) Fucoidan induces G1 arrest of the cell cycle in EJ human bladder cancer cells through down-regulation of pRB phosphorylation. Revista Brasileira de Farmacognosia 25:3, pages 246-251.
Crossref
Crossref
Leyla Kavandi, Laura R. Lee, Amber A. Bokhari, John E. Pirog, Yongping Jiang, Kashif A. Ahmad & Viqar Syed. (2015)
The Chinese herbs
Scutellaria baicalensis
and
Fritillaria cirrhosa
target NFκB to inhibit proliferation of ovarian and endometrial cancer cells
. Molecular Carcinogenesis 54:5, pages 368-378.
Crossref
Crossref
Janaina Fernandes. 2015. Bioactive Essential Oils and Cancer. Bioactive Essential Oils and Cancer
175
200
.
Dale Han & Keiran SM Smalley. 2015. BRAF Targets in Melanoma. BRAF Targets in Melanoma
137
162
.
E X Chen, S Hotte, H Hirte, L L Siu, J Lyons, M Squires, S Lovell, S Turner, L McIntosh & L Seymour. (2014) A Phase I study of cyclin-dependent kinase inhibitor, AT7519, in patients with advanced cancer: NCIC Clinical Trials Group IND 177. British Journal of Cancer 111:12, pages 2262-2267.
Crossref
Crossref
Claire Fabre, Marco Gobbi, Cyrine Ezzili, Mustapha Zoubir, Marie-Paule Sablin, Karen Small, Ellie Im, Nabeegha Shinwari, Da Zhang, Honghong Zhou & Christophe Le Tourneau. (2014) Clinical study of the novel cyclin-dependent kinase inhibitor dinaciclib in combination with rituximab in relapsed/refractory chronic lymphocytic leukemia patients. Cancer Chemotherapy and Pharmacology 74:5, pages 1057-1064.
Crossref
Crossref
Felicia Phei Lin Lim & Anton V. Dolzhenko. (2014) 1,3,5-Triazine-based analogues of purine: From isosteres to privileged scaffolds in medicinal chemistry. European Journal of Medicinal Chemistry 85, pages 371-390.
Crossref
Crossref
Gaëlle Mariaule & Philippe Belmont. (2014) Cyclin-Dependent Kinase Inhibitors as Marketed Anticancer Drugs: Where Are We Now? A Short Survey. Molecules 19:9, pages 14366-14382.
Crossref
Crossref
Jasmina Makarević, Jochen Rutz, Eva Juengel, Silke Kaulfuss, Michael Reiter, Igor Tsaur, Georg Bartsch, Axel Haferkamp & Roman A. Blaheta. (2014) Amygdalin Blocks Bladder Cancer Cell Growth In Vitro by Diminishing Cyclin A and cdk2. PLoS ONE 9:8, pages e105590.
Crossref
Crossref
Jing Ma, Su Liu & Yafei Wang. (2014) MicroRNA-21 and multiple myeloma: small molecule and big function. Medical Oncology 31:8.
Crossref
Crossref
Theresa PlackeKatrin FaberAtsushi NonamiSarah L. PutwainHelmut R. SalihFlorian H. HeidelAlwin KrämerDavid E. RootDavid A. BarbieAndrei V. KrivtsovScott A. ArmstrongWilliam C. HahnBrian J. HuntlyStephen M. Sykes, Michael D. Milsom, Claudia SchollStefan Fröhling. (2014) Requirement for CDK6 in MLL-rearranged acute myeloid leukemia. Blood 124:1, pages 13-23.
Crossref
Crossref
JIN-WOO JEONG, SEJIN PARK, CHEOL PARK, YOUNG-CHAE CHANG, DONG-OH MOON, SUNG OK KIM, GI-YOUNG KIM, HEE-JAE CHA, HEUI-SOO KIM, YOUNG-WHAN CHOI, WUN-JAE KIM, YOUNG HYUN YOO & YUNG HYUN CHOI. (2014) N-benzyl-N-methyldecan-1-amine, a phenylamine derivative isolated from garlic cloves, induces G2/M phase arrest and apoptosis in U937 human leukemia cells. Oncology Reports 32:1, pages 373-381.
Crossref
Crossref
Mehmet Topcul & Idil Cetin. (2014) Endpoint of Cancer Treatment: Targeted Therapies. Asian Pacific Journal of Cancer Prevention 15:11, pages 4395-4403.
Crossref
Crossref
Jaclyn E. Quin, Jennifer R. Devlin, Donald Cameron, Kate M. Hannan, Richard B. Pearson & Ross D. Hannan. (2014) Targeting the nucleolus for cancer intervention. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1842:6, pages 802-816.
Crossref
Crossref
Gui'e Xie, Hongping Tang, Shaoqing Wu, Jingsong Chen, Jiangwen Liu & Can Liao. (2014) The cyclin-dependent kinase inhibitor SNS-032 induces apoptosis in breast cancer cells via depletion of Mcl-1 and X-linked inhibitor of apoptosis protein and displays antitumor activity in vivo. International Journal of Oncology.
Crossref
Crossref
Hye Park, Gi-Young Kim, Sung-Kwon Moon, Wun Kim, Young Yoo & Yung Choi. (2014) Fucoidan Inhibits the Proliferation of Human Urinary Bladder Cancer T24 Cells by Blocking Cell Cycle Progression and Inducing Apoptosis. Molecules 19:5, pages 5981-5998.
Crossref
Crossref
Todd M. Pitts, S. Lindsey Davis, S. Gail Eckhardt & Erica L. Bradshaw-Pierce. (2014) Targeting nuclear kinases in cancer: Development of cell cycle kinase inhibitors. Pharmacology & Therapeutics 142:2, pages 258-269.
Crossref
Crossref
CHEOL PARK, NA YOUNG JEONG, GI-YOUNG KIM, MIN HO HAN, ILL-MIN CHUNG, WUN-JAE KIM, YOUNG HYUN YOO & YUNG HYUN CHOI. (2014) Momilactone B induces apoptosis and G1 arrest of the cell cycle in human monocytic leukemia U937 cells through downregulation of pRB phosphorylation and induction of the cyclin-dependent kinase inhibitor p21Waf1/Cip1. Oncology Reports 31:4, pages 1653-1660.
Crossref
Crossref
Constantinos G. Broustas & Howard B. Lieberman. (2014) DNA Damage Response Genes and the Development of Cancer Metastasis. Radiation Research 181:2, pages 111-130.
Crossref
Crossref
Hyun Soo Park, Min Ho Han, Gi-Young Kim, Sung-Kwon Moon, Wun-Jae Kim, Hye Jin Hwang, Kun Young Park & Yung Hyun Choi. (2014) Sulforaphane induces reactive oxygen species-mediated mitotic arrest and subsequent apoptosis in human bladder cancer 5637 cells. Food and Chemical Toxicology 64, pages 157-165.
Crossref
Crossref
Robert J. Huber. (2013) The cyclin-dependent kinase family in the social amoebozoan Dictyostelium discoideum. Cellular and Molecular Life Sciences 71:4, pages 629-639.
Crossref
Crossref
SHAO-KANG WANG, TING-TING WANG, GUI-LING HUANG, RUO-FU SHI, LI-GANG YANG & GUI-JU SUN. (2014) Stimulation of the proliferation of human normal esophageal epithelial cells by fumonisin B1 and its mechanism. Experimental and Therapeutic Medicine 7:1, pages 55-60.
Crossref
Crossref
A. Mortlock, K. Foote, J. Kettle & B. Aquila. 2014. Reference Module in Chemistry, Molecular Sciences and Chemical Engineering. Reference Module in Chemistry, Molecular Sciences and Chemical Engineering.
D Cirstea, T Hideshima, L Santo, H Eda, Y Mishima, N Nemani, Y Hu, N Mimura, F Cottini, G Gorgun, H Ohguchi, R Suzuki, H Loferer, N C Munshi, K C Anderson & N Raje. (2013) Small-molecule multi-targeted kinase inhibitor RGB-286638 triggers P53-dependent and -independent anti-multiple myeloma activity through inhibition of transcriptional CDKs. Leukemia 27:12, pages 2366-2375.
Crossref
Crossref
JulieAnn Rader, Mike R. Russell, Lori S. Hart, Michael S. Nakazawa, Lili T. Belcastro, Daniel Martinez, Yimei Li, Erica L. Carpenter, Edward F. Attiyeh, Sharon J. Diskin, Sunkyu Kim, Sudha Parasuraman, Giordano Caponigro, Robert W. Schnepp, Andrew C. Wood, Bruce Pawel, Kristina A. Cole & John M. Maris. (2013) Dual CDK4/CDK6 Inhibition Induces Cell-Cycle Arrest and Senescence in Neuroblastoma. Clinical Cancer Research 19:22, pages 6173-6182.
Crossref
Crossref
Marie-Hélène Teiten, François Gaascht, Mario Dicato & Marc Diederich. (2013) Anticancer bioactivity of compounds from medicinal plants used in European medieval traditions. Biochemical Pharmacology 86:9, pages 1239-1247.
Crossref
Crossref
Sunil Kumar Tripathi, Ravikumar Muttineni & Sanjeev Kumar Singh. (2013) Extra precision docking, free energy calculation and molecular dynamics simulation studies of CDK2 inhibitors. Journal of Theoretical Biology 334, pages 87-100.
Crossref
Crossref
Laura R. Lee, Pang-Ning Teng, Huyen Nguyen, Brian L. Hood, Leyla Kavandi, Guisong Wang, Jane M. Turbov, Larry G. Thaete, Chad A. Hamilton, George L. Maxwell, Gustavo C. Rodriguez, Thomas P. Conrads & Viqar Syed. (2013) Progesterone Enhances Calcitriol Antitumor Activity by Upregulating Vitamin D Receptor Expression and Promoting Apoptosis in Endometrial Cancer Cells. Cancer Prevention Research 6:7, pages 731-743.
Crossref
Crossref
Stephan C. Jahn, Mary E. Law, Patrick E. Corsino, Thomas C. Rowe, Bradley J. Davis & Brian K. Law. (2013) Assembly, Activation, and Substrate Specificity of Cyclin D1/Cdk2 Complexes. Biochemistry 52:20, pages 3489-3501.
Crossref
Crossref
Abhik Saha & Erle S Robertson. (2013) Impact of EBV essential nuclear protein EBNA-3C on B-cell proliferation and apoptosis. Future Microbiology 8:3, pages 323-352.
Crossref
Crossref
Terry Farrah, Eric W. Deutsch, Michael R. Hoopmann, Janice L. Hallows, Zhi Sun, Chung-Ying Huang & Robert L. Moritz. (2012) The State of the Human Proteome in 2012 as Viewed through PeptideAtlas. Journal of Proteome Research 12:1, pages 162-171.
Crossref
Crossref
Yun Dai, Shuang Chen, Liang Yi & Minhui Xu. 2013. Trends in Stem Cell Proliferation and Cancer Research. Trends in Stem Cell Proliferation and Cancer Research
591
654
.
Katharina Spanel-BorowskiKatharina Spanel-Borowski. 2012. Atlas of the Mammalian Ovary. Atlas of the Mammalian Ovary
99
107
.